Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Morton

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trialsC L Loprinzi, E M Messing, J R O'Fallon, et al.
Oncology|October 1, 1994
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, A M Bernath, D J Schaid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG studyG K Dy, A A Miller, S J Mandrekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, J C Michalak, D J Schaid, et al.
Cancer|March 15, 1992
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracilJ A Laurie, R G Hahn, T M Therneau, et al.
American Journal of Clinical Oncology|February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancerR F Marschke, J P Grill, J A Sloan, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
Journal of Neuro-Oncology|December 1, 1996
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumorT L Cascino, M H Veeder, J C Buckner, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1996
Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trialsC L Loprinzi, E M Messing, J R O'Fallon, et al.
Oncology|October 1, 1994
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, A M Bernath, D J Schaid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2005
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG studyG K Dy, A A Miller, S J Mandrekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, J C Michalak, D J Schaid, et al.
Cancer|March 15, 1992
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracilJ A Laurie, R G Hahn, T M Therneau, et al.
American Journal of Clinical Oncology|February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancerR F Marschke, J P Grill, J A Sloan, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
Journal of Neuro-Oncology|December 1, 1996
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumorT L Cascino, M H Veeder, J C Buckner, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase II study of amonafide in patients with recurrent gliomaR Levitt, J C Buckner, T L Cascino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
Pageof 7